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Microglia are the main immune cells of the brain and contribute to common brain diseases.
However, it is unclear how microglia inﬂuence neuronal activity and survival in the injured
brain in vivo. Here we develop a precisely controlled model of brain injury induced by cerebral
ischaemia combined with fast in vivo two-photon calcium imaging and selective microglial
manipulation. We show that selective elimination of microglia leads to a striking, 60%
increase in infarct size, which is reversed by microglial repopulation. Microglia-mediated
protection includes reduction of excitotoxic injury, since an absence of microglia leads to
dysregulated neuronal calcium responses, calcium overload and increased neuronal death.
Furthermore, the incidence of spreading depolarization (SD) is markedly reduced in the
absence of microglia. Thus, microglia are involved in changes in neuronal network activity and
SD after brain injury in vivo that could have important implications for common brain
diseases.
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M
icroglia are the main resident immune-competent cell
population of the central nervous system (CNS),
and play an essential role in CNS development,
maintenance and repair1. However, altered microglial activity is
associated with common human diseases, such as migraine,
stroke, dementia, traumatic injury, epilepsy and Parkinson’s
disease: these affect millions of people worldwide, representing
a high socioeconomic burden2–4. In fact, microglia are capable
of producing a diverse array of inﬂammatory mediators in
response to injury or infection, and inﬂammation is linked with
poor clinical outcome in CNS diseases3–5. At the same time,
data also indicate that speciﬁc microglial actions can be
neuroprotective6. Thus, the role of microglia in brain injury is
controversial and disease dependent, whereas the mechanisms
through which microglia contribute to brain injury or repair are
unclear.
Microglia are highly dynamic, and constantly survey the brain
parenchyma, showing rapid activation in response to harmful
stimuli7. In vivo two-photon imaging studies have revealed that
microglial processes interact with capillaries, react to vascular or
parenchymal injury in the brain, monitor the state of synapses
and remove injured neurons, their processes or synaptic
structures in different models of brain injury7–11. Recently,
microglia have also been shown to react to changes in
extracellular calcium levels12. It is currently debated whether
microglia could promote excitotoxicity (a major cause of
neuronal death induced by calcium overload) via production of
proinﬂammatory mediators13,14, or whether speciﬁc microglial
actions could reduce excitotoxic neuronal death15,16. It is also
unclear whether microglia could play a role in spreading
depolarization (SD), one of the most fundamental processes of
brain pathology17 that involves swelling of neurons, injury to
dendritic spines and subsequent silencing of brain electrical
activity, which is linked with excitotoxicity and general outcome
in common brain diseases such as stroke, brain haemorrhage,
epilepsy and migraine18–20. However, the functional role of
microglia in shaping the activity of complex neuronal networks is
difﬁcult to study in vivo, since the large similarity between
microglia and other tissue macrophages has not allowed selective
in vivo manipulation of microglia until very recently6,21. Also,
it has proved to be difﬁcult to perform long-term monitoring of
fast neuronal responses in the context of microglial activity in
real time.
Microglia arise from yolk sac-derived precursors that populate
the brain during early development21. Microglia genesis is
dependent on the transcription factors IRF8 and PU.1 (ref. 22),
but, once migrated to the neuroectoderm, microglia become
self-renewing, which requires colony-stimulating factor 1
receptor (CSF1R)-dependent signalling23. High-dose treatment
with a brain-penetrant CSF1R kinase inhibitor reversibly depletes
microglia, an effect that has no apparent gross deleterious results
in healthy mice, but that provides a powerful tool for inferring the
various roles of microglia in more detail24.
Strikingly, we found that selective elimination of microglia
from the brain leads to markedly augmented neuronal death
after acute brain injury. To study the mechanisms involved,
we combined fast multicolour two-photon imaging of
genetically encoded calcium indicators (GECI) with a
recently developed remote ﬁlament model of middle cerebral
artery occlusion (MCAo) allowing us to monitor microglial
responses and fast neuronal activity changes simultaneously,
in real time. We show that an absence of microglia results
in dysregulated neuronal responses, lack of SD and
increased excitotoxic injury. Thus, supporting beneﬁcial
microglial–neuronal interactions could have profound
therapeutic implications.
Results
CSF1R blockade leads to selective microglia depletion.
Microglia have been implicated in both vascular 9,25 and neuronal
injury26,27, and neuroprotection28,29, but tools to selectively
manipulate microglia have become available only very
recently24,30,31. To reduce the potential side effects of microglia
manipulation to the minimum, we made use of the discovery that
microglial survival is critically dependent on CSF1R signalling, in
contrast to other tissue macrophages23,24,31. Feeding a chow diet
containing the CSF1R antagonist PLX3397 (290 p.p.m.) for
3 weeks resulted in an almost complete elimination of microglia
from the brain in Cx3Cr1GFP/þmice, as conﬁrmed by the absence
of green ﬂuorescent protein (GFP)-positive cells that co-expressed
the microglia/macrophage marker Iba1 (Fig. 1a). Quantitative
analysis showed that after 3 weeks, 97% of microglia were
eliminated from the cerebral cortex and 93% from the striatum,
compared with control mice (Fig. 1b). Microglia were eliminated
as a result of apoptosis, as indicated by the expression of the
apoptotic marker Cleaved Caspase-3 in microglia, but not in
neurons (Fig. 1c) or other cells (not shown). Correspondingly, no
sign of brain inﬂammation, leukocyte recruitment, weight loss or
increases in circulating inﬂammatory citokines were observed
over 3 weeks of PLX3397 treatment (Supplementary Fig. 1),
conﬁrming previous results24,32. No sign of blood brain barrier
(BBB) injury, as assessed by IgG penetration into the brain
parenchyma was found similarly to earlier observations24. The
number of neurons, pericytes, astrocytes and levels of the tight
junction protein claudin 5 were not altered in the brain
(Supplementary Fig. 2a, b) and no changes were seen in spleen
macrophages and splenic or blood leukocyte populations
(Supplementary Figs 3 and 4). Thus, we argued that this model
of selective microglial ablation introduces minimal disturbance to
the brain and does not alter peripheral leukocytes, enabling us to
study the role of microglia in brain injury.
Absence of microglia results in increased brain injury. Next, we
designed a series of experiments to assess the role of microglia in
brain injury and to control for the potential confounding effects
PLX3397 might exert on neuronal injury. As earlier, an almost
complete elimination of microglia (Iba1þ cells) from the brain
was observed after feeding mice a chow diet containing PLX3397
for 21 days (Fig. 1d). Since PLX3397 is quickly cleared from
central and peripheral tissues24, the PLX3397 diet was withdrawn
for 24 h after 21 days of microglia depletion in a separate group of
animals, after which microglia remained fully depleted, but only
trace amounts of the drug were detected in the brain24. Indeed,
we found that 98% of microglia were absent from the cerebral
cortex 24 h after drug withdrawal (Fig. 1d). In a further group of
animals, the drug was withdrawn for 2 weeks after 21 days of
treatment, which led to full repopulation of microglia (Fig. 1d).
No changes in splenic Iba1þ macrophages were seen in any of
the experimental groups (Fig. 1e). The absence of microglia
resulted in a striking, 60% increase in infarct size 24 h after MCAo
(26.8mm3 in control versus 42.8mm3 in microglia-depleted
animals), which was not affected by the presence of PLX3397, as
increased infarct size (41.2mm3) was also seen if PLX3397 was
withdrawn 24 h before cerebral ischaemia (Fig. 1f). In contrast,
repopulation of microglia completely reversed the effect of
microglia depletion on increased infarct size (22.5mm3),
implying that the presence of microglia inﬂuences the severity
of brain injury after cerebral ischaemia. We also investigated
whether any of the treatment protocols affected cerebral blood
ﬂow (CBF), but no differences in CBF values were found after
occlusion of the MCA (Fig. 1g) or at reperfusion (not shown)
compared with baseline. Levels of interleukin 6 (IL-6)—a
ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms11499
2 NATURE COMMUNICATIONS | 7:11499 | DOI: 10.1038/ncomms11499 | www.nature.com/naturecommunications
cytokine produced by microglia1—in the cerebrospinal ﬂuid
mirrored the differences seen in microglial numbers across the
different experimental groups 24 h after cerebral ischaemia
(Fig. 1h). Absence of microglia did not lead to increased
leukocyte recruitment to the brain 24 h (Fig. 1i) and 72 h
(Supplementary Fig. 5) after cerebral ischaemia or inﬂammation
as observed previously by others after hippocampal injury24.
In addition, Iba1-positive microglia/macrophages were still
profoundly reduced in the brain 72 h after MCAo, suggesting
that an absence of microglia (and larger brain injury) does
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Figure 1 | Absence of microglia results in markedly increased brain injury after cerebral ischaemia. (a) Cx3Cr1GFP/þ mice were fed a chow diet
containing the CSF1R antagonist PLX3397 (290p.p.m.) for 21 days, which resulted in an almost complete elimination of resident brain microglia. Absence
of microglia was conﬁrmed by the lack of both GFP (green) and Iba1 (red) signal. Arrowhead indicates microglia (bottom panel). (b) Quantiﬁcation of
microglia in C57BL6/J mice after control or PLX3397 diet. (c) PLX3397 results in microglial apoptosis as indicated by the activation of Cleaved Caspase-3
(Casp3, red) in microglia (GFP, green) in Cx3Cr1GFP/þ mice (arrowheads). No Caspase-3 expression is seen in neurons (NeuN, blue). (d) Elimination of
microglia (Iba1-positive cells) from the brain is seen after feeding mice a chow diet containing PLX3397 for 21 days (Depl. PLX þ ). Microglia remain
depleted when the diet is withdrawn for 24 h after 21 days of treatment (Depl. PLX ). Microglial repopulation occurs 2 weeks after diet withdrawal
(Depl. Rep.). (e) No changes are seen in Iba1-positive spleen macrophages in response PLX3397 or after microglial repopulation. (f) An absence of
microglia leads to markedly increased infarct size 24 h after cerebral ischaemia, which is reversed by microglial repopulation. (g) Cerebral blood ﬂow (CBF)
was measured by a laser Doppler during MCA occlusion (expressed as % of baseline). (h) IL-6 levels in the CSF 24 h after cerebral ischaemia.
(i) Elimination of microglia did not increase the recruitment of CD45-positive leukocytes into the brain 24 h after cerebral ischemia. (j) Intraperitoneal
administration of PLX3397 1 h after the onset of ischaemia did not alter brain injury as assessed 24 h after MCAo. Data are expressed as mean±s.e.m.
b: two-way analysis of variance (ANOVA) followed by Sidak’s multiple comparison, N¼8–10; d–i: one-way ANOVA followed by Tukey’s multiple
comparison, N¼ 7–11; (j): unpaired t test, N¼ 7, *Po0.05, **Po0.01, ****Po0.0001 versus the control group; ###Po0.001 versus Depl. Rep;
NS, not signiﬁcant. Scale bars, a, 100mm; c, 10mm.
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not lead to signiﬁcantly increased monocyte inﬂux compared
with control mice. We also investigated whether a single,
intraperitoneal injection of 20mg kg 1 PLX3397, which
resulted in 25,930±3,600 ngml 1 PLX3397 concentrations in
the plasma and 1,160±290 ng g 1 (2.8±0.7 mM) concentrations
in the intact (non-ischaemic) brain tissue (Supplementary Fig. 6)
could exert any effect on neuronal injury. This regimen yields
higher PLX3397 levels than that needed to maintain depletion of
microglia24, but does not lead to microglia depletion. Mice that
received a single, acute dose of 20mg kg 1 PLX3397 60min after
MCAo, when BBB injury takes place based on our two-photon
imaging data (see below), showed no changes in infarct size
24 h after reperfusion compared with controls (Fig. 1j), while
microglial numbers were not reduced (Supplementary Fig. 6).
Thus, these data suggest that an absence of microglia leads to
increased brain injury independently of PLX3397 and that
PLX3397 itself has no detrimental effect on neuronal injury in
this model.
Absence of microglia facilitates excitotoxicity. Next, we used
in vivo two-photon calcium imaging combined with a recently
developed remote ﬁlament model of MCAo to investigate the
mechanisms through which microglia contribute to brain
protection after acute injury. To this end, adeno-associated virus
(AAV)-mediated delivery of the GECIs, GCaMP6s or RCaMP1
was performed using a micropipette distant from the imaging site.
This minimized disturbance to the brain tissue, as evidenced by
the absence of microglial activation in the imaging area where the
dura mater was not injured (see Methods section and
Supplementary Fig. 7a). This system enabled precise and con-
tinous monitoring of neuronal calcium changes and network
activity in the cerebral cortex in real time, up to several hours post
reperfusion (Fig. 2a). In a separate set of experiments, series of
CBF measurements were performed by laser Doppler ﬂowmetry
to establish the site of our imaging window (30 measurements
performed in n¼ 5 mice). To capture neuronal GCaMP6s signal
changes in the evolving infarct, the imaging site was positioned
between an area with close to maximal CBF reduction (80%
reduction to baseline) and an area with sub-ischaemic levels of
blood ﬂow (30% reduction to baseline, Fig. 2b). In response to
induction of cerebral ischaemia for 60min, we noticed minor
increases of the GCaMP6s signal in cortical neurons and the
neuropil followed by low levels of GCaMP6s signal up to 1–1.5 h
after the induction of reperfusion (Fig. 2c,d). In contrast, a
marked increase in intracellular calcium was observed 1.5–3 h
after reperfusion in the same neurons and the neuropil caused by
the initiation of SD, a basic phenomenon of brain pathology
thought to contribute to excitotoxicity and linked with neuronal
injury in diverse neurological diseases18,20 (Fig. 2d,e and
Supplementary Video 1). Series of two to four SDs in
individual mice were followed by a reduction in neuronal
calcium signals by 4 h of reperfusion (Fig. 2d–f), which
remained similar 24 h after cerebral ischaemia (Supplementary
Fig. 7B). Quantitative analysis of GCaMP6s signal changes over
time showed that signiﬁcant increases in neuronal calcium levels
develop only 1.5–3 h after the induction of reperfusion due to
repeated SDs (Fig. 2f). The GCaMP6s signal remained unaltered
in sham animals over the whole imaging period.
Microglia contact neurons in an activity-dependent manner.
Several excellent previous studies have investigated microglial
responses after brain injury using two-photon microscopy1,7,8,10,
but in vivo two-photon imaging to evaluate the relationship
between microglial actions and neuronal network activity has not
been performed in real time. Our histological data suggested that
after cerebral ischaemia, microglia and their processes surround
neurons showing high GCaMP6s signal in the boundary zones of
the infarct (Fig. 3a). To investigate this in real time, neuronal
calcium responses were monitored with two-photon microscopy
using the GECI RCaMP1, in Cx3Cr1GFP/þ (microglia reporter)
mice (Fig. 3b). Cerebral ischaemia resulted in similar RCaMP1
changes as seen earlier with GCaMP6s. Morphological signs of
microglial activation (reduced ramiﬁcation and thickened
processes) were seen between 1 and 4 h after the onset of
ischaemia in the evolving infarct as also conﬁrmed by Sholl
analysis33. Microglial activation was associated with enlargement
of the cell body and increased Iba1 expression from 6h
after cerebral ischaemia (Supplementary Fig. 8). Importantly,
microglial processes, which were frequently found to touch
neuronal cell bodies and dendrites already before MCAo, were
extended to neurons showing increasing RCaMP1 signal over
time, surrounding the cell body and the main dendrites, whereas
microglial processes were withdrawn after prolonged reduction
in neuronal intracellular calcium levels (Fig. 3b–d and
Supplementary Video 2). We also assessed changes in the
density of microglial processes in concentric circles around
individual neurons (a modiﬁcation of Sholl analysis33, see
Methods section), which showed increasing microglial process
coverage (R2¼ 0.9, P¼ 0.0038) of neurons showing a sustained
rise in intracellular calcium after cerebral ischaemia (Fig. 3e).
Surprisingly, we also found that SDs that typically occurred
1.5–3 h after the onset of cerebral ischaemia increased microglial
process coverage of neuronal cell bodies within 30min in both
neurons showing increasing RCaMP1 signal before and after an
SD (termed as Group 1 cells) and in those cells where intracellular
calcium returned to near-baseline levels after SD (termed as
Group 2 cells; Fig. 3f–h, Supplementary Fig. 9 and Supplementary
Video 3). Super-resolution microscopy revealed that ﬁne
microglial processes form tight contacts with the neuronal cell
body in the evolving infarct, whereas fewer microglia–neuron
contacts were seen around the neuronal cell body in sham
animals. Microglial P2Y12 receptors were found clustering at the
microglia–neuron interface independently of location of astrocyte
endfeet (Fig. 3i–j and Supplementary Fig 10). Thus, microglia
react rapidly to changes in intracellular calcium in neurons and
SD is associated with microglial process recruitment to neurons
independently of sustained calcium changes in the injured brain.
Lack of microglia alters neuronal activity and SD after injury.
Our imaging data indicated that microglia contact neurons in an
activity-dependent manner after brain injury, which led us
to investigate neuronal calcium responses in the absence of
microglia. To this end, two weeks after GCaMP6s delivery,
repeated 2-min-long, fast two-photon imaging recordings were
performed by resonant scanning, separated by 5min breaks over
a 5.5–6 h period before and after the induction of 60min MCAo
followed by reperfusion. Selective microglia depletion did
not inﬂuence GCaMP6s delivery to cortical neurons (456±78
neurons per mm2 in control and 504±35 neurons per mm2 in
microglia-depleted mice were GCaMP6s-positive in the imaging
area before MCAo being induced). As earlier, we found that
cerebral ischaemia resulted in negligible GCaMP6s signal changes
in control mice during occlusion and early reperfusion, followed
by the occurrence of repeated SDs 1.5–3 h after reperfusion in
the evolving infarct. Calcium imaging revealed few changes in
individual neurons or in the neuropil before SD (Fig. 4a, left). In
contrast, in the absence of microglia striking increases in slow
neuronal oscillations were observed 15–25min after the onset of
ischaemia, which continued after the induction of reperfusion up
to 3–5 h post MCAo (Fig. 4a right, and Supplementary Video 4).
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Surprisingly, an absence of microglia was associated with the
complete lack of SD in microglia-depleted animals after brain
injury (Fig. 4a,b). Hence, average GCaMP6s signal levels did not
increase 1.5–3 h after reperfusion as seen in control mice (Fig. 4c).
However, cumulative calcium load as calculated by summing up
calcium curve integrales from the 2-min resonant scanning
sessions of individual neurons over an 5.5 h imaging period, was
signiﬁcantly (over fourfold) higher in microglia-depleted mice
compared with controls (Fig. 4d). This difference was striking
considering that SDs contributed substantially to cumulative
calcium load in control mice, whereas no SDs were seen in the
absence of microglia. Moreover, we calculated the time spent
before increases in intracellular calcium load become evident in
individual neurons, which was markedly shorter in the absence
of microglia (Fig. 4e). To investigate whether the increased
cumulative calcium load seen in the ﬁrst hours after ischaemia/
reperfusion is associated with subsequent neuronal injury, we
investigated the fate of affected neurons at the imaging site 24 h
after cerebral ischaemia. We found a signiﬁcant (20%) reduction
in the number of cresyl violet-stained neurons 24 h after cerebral
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ischaemia in control mice, which was markedly augmented
(by over twofold) in microglia-depleted animals (Fig. 4f,g).
Lack of microglia alters neuronal responses to KCl. To test
whether an absence of microglia leads to altered neuronal calcium
dynamics in the non-ischaemic brain, we applied potassium
chloride (KCl) topically to the surface of the cerebral cortex,
which is widely used to induce neuronal depolarization and
SD19,34. Spontaneous calcium responses before KCl application
and calcium responses during SD showed a good correlation
with changes in local ﬁeld potential (Supplementary Fig. 11). In
control mice, SD was readily induced within 0.5–3min after
administration of 100mM KCl with an obvious propagating
wavefront as evidenced by GCaMP6s signal changes during
fast in vivo two-photon imaging (Fig. 5a,b and Supplementary
Video 5). In contrast, similar SD to that seen in control mice was
rarely observed in the absence of microglia. In some cases a pale
wavefront was seen, resulting from increases of GCaMP6s signal
(considered as an SD for quantiﬁcation) in neuronal cell bodies
and the neuropil (Fig. 5b and Supplementary Video 6). Repeated
KCl application (three times, over the course of 2 h) resulted in
only 20% probability of SD in the absence of microglia as opposed
to 80% in animals with functional microglia in the brain (Fig. 5c).
Quantitative analysis showed that GCaMP6s signal increases in
individual neurons over baseline values after KCl administration
took place with signiﬁcant latency (mean 17min) in the absence
of microglia, compared to control mice (2.5min, Fig. 5d). In
addition, integration of calcium curves of individual neurons
revealed a marked reduction in KCl-induced depolarization in
microglia-depleted mice (Fig. 5e). Thus, modulation of neuronal
activity by microglia-mediated actions appears to be a basic
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physiological phenomenon that is evident in both the intact and
the injured brain.
Lack of microglia does not augment BBB injury after stroke.
Since previous studies implicated microglia in vascular injury
after cerebral ischaemia9, we tested whether altered BBB injury
could be responsible for some of the changes we obsered in
microglia-depleted animals. In vivo two-photon recordings of
Z-stacks in Cx3Cr1GFP/þ mice with RCaMP1 (Fig. 3b) and
histological analysis (Supplementary Fig. 12A) revealed that
individual microglial cells extended processes to 6–12 nearby
neurons on average, located 15–80 mm away from the microglial
cell body. In addition, microglia contacting neurons were
often found in the vicinity of capillaries, or extended their
processes to distant microvessels. Using Cx3Cr1GFP/þ mice
injected intravenously with a red ﬂuorescent tracer, Dextran
rhodamine (70,000 molecular weight), we set out to visualize sites
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of BBB injury that have been associated with altered microglial
activity in previous studies25,35. BBB injury at the level of
microvessels and arterioles occurred typically 50–90min after the
onset of ischaemia. Microglia located in the vicinity of blood
vessels were recruited to the injured sites and displayed
an activated phenotype within 15–40min followed by partial
withdrawal of their processes (Supplementary Fig. 12b). However,
we found that elimination of microglia did not result in any
signiﬁcant alterations in the kinetics of BBB injury as assessed by
in vivo two-photon imaging (Fig. 6) based on the extravasation of
intravenously injected Dextran rhodamine in Cx3Cr1GFP/þ mice.
Quantitative analysis showed that signiﬁcant BBB injury in the
brain parenchyma takes place 60min after the onset of ischaemia
(analysis of variance, Po0.05) in both control and microglia-
depleted animals, but control and microglia-depleted animals did
not signiﬁcantly differ (Fig. 6b). Similarly, no differences were
seen in the glia limitans in control versus microglia-depleted mice
(Fig. 6c). In addition, an absence of microglia did not alter BBB
injury 24 h after MCAo as assessed on coronal brain sections
based on leakage of circulating IgG into the brain parenchyma
(Fig. 6d). Thus, these data strongly suggest that microglia-
mediated protective effects after brain injury are due to the
regulation of neuronal activity by microglia and not to effects on
the extent or kinetics of vascular injury. We also found blunted
upregulation of IL-1a, tumour necrosis factor-a (TNFa), IL-6,
monocyte chemoattractant protein-1 (MCP-1), KC (CXCL1) and
IL-4 in the ipsilateral hemisphere 8 h after cerebral ischaemia in
the absence of microglia (Supplementary Fig. 13), indicating that
increased brain injury and changes in neuronal responses are not
explained by exaggerated inﬂammatory responses in this model of
microglia depletion.
Discussion
Here we identify microglia as important components of the
neuronal response to brain injury and show that microglia protect
against neuronal injury. Selective removal of microglia from the
brain leads to the dysregulation of neuronal calcium responses
and network activity, increased calcium accumulation and
markedly reduced SD incidence after brain injury, which is
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associated with profoundly increased neuronal loss. Therefore,
selective targeting of the pathways involved could have a
critical impact on understanding the pathophysiology of
common human diseases and the development of novel
therapeutic approaches.
The role of microglia in the healthy brain and in neurological
diseases remains highly controversial, in spite of the substantial
research effort and recent breakthroughs in this ﬁeld1,2,21.
Microglia, the resident immune cells of the brain, appear to be
essential for normal brain function, whereas altered microglial
function has been linked with diverse brain pathologies in
both humans and experimental animals. These include
diseases with a high socioeconomic burden such as depression,
psychiatric diseases, epilepsy, stroke, migraine, Parkinson’s
disease and various forms of dementia such as Alzheimer’s
disease2,3,5,6,26,28,36. The controversies regarding the possible
detrimental or protective role for microglia in different models of
neurological diseases are likely due to multiple factors. Of these,
the immunological and functional similarities between microglia
and peripheral macrophages have made it difﬁcult, until very
recently, to selectively manipulate microglia6,24. Most microglia
in the brain are protected by the BBB (except for the cells that
reside in the circumventricular organs), and are hence difﬁcult to
target, while microglia become rapidly activated in response to
any disturbance to the brain or after peripheral inﬂammatory
challenges, which can shape microglial responses and outcome
after different forms of brain injury1,5,7. It is important to note
that none of the previous studies combined selective microglial
depletion with high-resolution two-photon calcium imaging
in vivo, to link microglial function with neuronal activity and
injury in real time.
We, therefore, established a model of brain injury that allowed
us to monitor both microglia–neuron interactions in real time
and the effects of microglial depletion on neuronal activity and
injury. During preliminary experiments, a model for GCaMP6s
delivery was developed to minimize the disturbance of neurons or
microglia at the imaging site, while the remote ﬁlament model of
cerebral ischaemia allowed us to induce targeted injury in the
brain without focal surgical intervention in the cerebral cortex.
Elimination of microglia using CSF1R blockade was selective, as it
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did not deplete peripheral myeloid cells, although a small,
non-signiﬁcant reduction in CD11blow Ly6cvhigh monocytes that
correspond toB2% of total blood leukocytes was noticed. This is
unlikely to have a major impact on neuronal activity and injury in
this model, especially considering the limited recruitment of
monocytes/macrophages compared to microglia in the brain at
24 h reperfusion after transient focal cerebral ischaemia37,38.
Depletion of microglia also had minimal impact on other cell
types in the brain. This is in line with previous observations using
the same approach24, which also demonstrated a lack of illness
and behavioural alterations in microglia-depleted animals24,32.
This might be due to the cessation of an essential survival signal
mediated by CSF1R, leading to the apoptotic death of microglia,
without the induction of inﬂammation. This regimen is expected
to cause fewer disturbances to the brain than applying toxic
substances that could lead to microglial activation or
inﬂammation. Depletion of microglia by genetic expression of
diphtheria toxin could lead to deﬁcits in learning and contextual
fear conditioning39, or cause cytokine expression in the brain31,
whereas toxicity to hematopoietic cells was observed in
CD11b-HSVTK mice in response to ganciclovir40. In addition,
microglia ablation by CSF1R blockade did not affect astrocytes, in
contrast to observations in microglia-depleted animals using the
Cx3Cr1CreER:iDTR model31.
Excitotoxicity is considered to be a major mechanism of
neuronal death that occurs due to intracellular calcium overload
followed by the activation of various cell death pathways41. After
global cerebral ischaemia, rapid, but reversible damage to
dendrites and spines was found to be caused by ischaemic
depolarizations immediately after cessation of blood ﬂow42. SD
was also observed with in vivo calcium imaging propagating from
the core of cortical microinfarcts43. We observed delayed
occurrence of SD in control mice after focal cerebral ischaemia
with small increases in intracellular calcium during MCA
occlusion. To our surprise, an absence of microglia completely
prevented SD after ischaemia, and markedly reduced the
incidence of SD following KCl administration in the non-
ischaemic brain. SD has been associated with neuronal injury in
stroke, epilepsy, migraine and other forms of brain injury18–20,34.
In vitro studies on rat hippocampal brain slices have suggested
that microglial polarization states could affect the SD threshold44.
However, the lack of SD in the ischaemic brain in the absence of
microglia in vivo was unexpected. Instead, the development of
slow neuronal oscillations as early as 15–25min after the onset
of ischaemia was seen, which was not due to immediate injury to
neurons, since slow oscillations were obseved even 2–3 h after
reperfusion in the same cells. The majority of the affected
neurons died within 24 h in the absence of microglia at the
imaging site unlike in control mice, indicating that altered
calcium responses could be involved in more pronounced
neuronal injury as widely supported by literature data45,46. Due
to the lack of research tools to inﬂuence SD independently of
changing neuronal activity, no mechanistic experiments could be
performed in this study to functionally link SD with neuronal
injury. However, our data suggest that at least after ischaemia,
neuronal death in complex neuronal networks following a series
of SDs could be lower than in response to dysregulated neuronal
network activity and long-lasting oscillations as seen in the
absence of microglia. Altered neuronal responses were observed
already 30–45min before BBB injury in microglia-depleted
animals after stroke and were also seen after KCl
administration, which does not lead to the disruption of the
BBB. Therefore, these data suggest that microglia could impact on
neuronal calcium responses and protect against neuronal injury
independently of vascular injury. Mice were anaesthetized during
imaging, which could alter neuronal responses47. However,
control and microglia-depleted mice were exposed to uniformly
low isoﬂurane levels (between 0.8 and 1.1%), hence the
anaesthetic is unlikely to contribute to the profoundly altered
neuronal responses seen in the absence of microglia. We have not
found differences in CBF after MCA occlusion and reperfusion
between control and microglia-depleted mice either, although we
are aware that laser Doppler measurements only reveal changes in
blood ﬂow relative to baseline values in the superﬁcial areas of the
cerebral cortex.
We have also investigated whether PLX3397 has any effect on
neuronal injury independently of microglia depletion. It has
been postulated that CSF1R signalling could contribute to
neuronal survival independently of microglia48. However, in
our experiments withdrawal of PLX3397 for 24 h, which reduces
drug concentrations to below detection level24, while microglia
remained depleted, resulted in increased brain injury, similar to
that seen in mice fed a PLX3397 diet at the time of MCAo.
Increases in brain injury were completely reversed after
repopulation of microglia. In addition, acute treatment with a
PLX3397 dose higher than that needed to block microglial
repopulation24 did not result in depletion of microglia and did
not alter brain injury. It is expected that BBB injury after cerebral
ischaemia would further increase PLX3397 levels in the brain.
These experiments suggest that larger brain injury in this model is
due to the absence of functional microglia. Data from previous
studies also support our conclusions. Elimination of microglia
from rat organotypic slice cultures in a CSF1R-independent
manner reduced the incidence of SD, whereas dampening of
microglial M1 signalling by minocycline or conditioned medium
from M2a-polarized primary microglia led to higher SD
threshold44. In addition, inhibition of proliferating microglial
cells in CD11b-TKmt-30 transgenic mice resulted in larger
ischaemic injury49. The effects of microglia depletion on
cerebral perfusion, somatosensory and motor responses, delayed
phases of neuronal injury and functional recovery, will need to be
investigated in future studies using models of brain injury and
neurodegeneration.
The exact molecular mechanisms through which microglia
sense and regulate neuronal activity are presently unclear but
investigation of the molecular pathways involved extends beyond
the scope of this already complex study. It is likely that microglia–
neuron signalling involves highly complex interactions between
metabolic pathways, neurotransmitters and their receptors,
ion channels and inﬂammatory mediators. Microglia–neuron
interactions in the optic tectum of the larval zebraﬁsh were found
to be dependent on neuronal pannexin-1 hemichannels and the
small Rho GTPase, Rac in microglia50. ATP triggers microglial
migration and process extension in both zebraﬁsh larvae and the
mammalian brain in vivo8,50. In fact, super-resolution microscopy
revealed increased microglial process coverage of neuronal cell
bodies after ischaemia and clustering of P2Y12 receptors on ﬁne
microglial processes at sites of microglia-neuron contacts,
although the functional role of purinergic signalling was not
investigated in this study. Glial ﬁbrillary acidic protein (GFAP)-
positive astrocyte processes have not been observed at the
microglia–neuron interface, but it is possible that some microglial
actions on neurons could be mediated via astrocytes. Microglia
are known to produce a diverse array of inﬂammatory mediators
that act directly on neurons and impact on neuronal activity and
injury. Some of these, such as IL-1 potentiate excitotoxicity and
neuronal injury5, while TNFa is known to alter the balance
between neuronal excitation and inhibition via different,
complementary mechanisms that involve neuronal AMPA,
NMDA and GABAA receptors51. Despite larger brain injury, an
absence of microglia was associated with blunted ischaemia-
induced production of both proinﬂammatory cytokines
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(IL-1a, TNFa) and cytokines that are considered to be
neuroprotective in the brain (IL-6, IL-4)52,53. Thus, the possible
contribution of these cytokines to brain injury remains to be
investigated further. The net effect of different microglial actions
on neuronal activity and injury could be highly dependent on the
dominance of certain pathophysiological mechanisms in different
CNS diseases. However, our data are the ﬁrst to demonstrate that
microglia markedly protect neurons against excitotoxicity and
injury after cerebral ischaemia in vivo, in spite of the plethora of
inﬂammatory mediators they produce.
Taken together, our results obtained by the combination of
high speed in vivo two-photon imaging with selective microglia
manipulation revealed a previously unrecognized link between
protective microglial actions and neuronal activity and injury.
These results could have profound implications on the patho-
physiology and potential treatment of major human diseases.
Methods
Mice. Experiments were carried out in 12–16 weeks old male C57BL/6J and
Cx3Cr1GFP/þmice, breeding in the speciﬁc-pathogen-free (SPF) unit of the Insti-
tute of Experimental Medicine. Animals were allowed free access to food and water
and were maintained under controlled temperature, humidity and light conditions.
All procedures were in accordance with STAIR and ARRIVE guidelines, and the
guidelines set by the European Communities Council Directive (86/609 EEC) and
the Hungarian Act of Animal Care and Experimentation (1998; XXVIII, section
243/1998), approved by the Animal Care and Use Committee of the Institute of
Experimental Medicine.
Selective elimination and repopulation of microglia. PLX3397 was provided
by Plexxikon and formulated in AIN-76A standard chow by Research Diets
(290 p.p.m.; 290mg PLX3397 in 1 kg chow). Mice were fed a PLX3397 diet for 3
weeks to eliminate microglia24. One group of mice was given PLX3397 for 3 weeks,
followed by withdrawal of the drug by replacing the PLX3397 diet with control
chow diet for 24 h before experiments. Another group of mice was fed PLX3397 for
3 weeks followed by 2 weeks on control diet to allow for the repopulation of
microglia in the brain. In agreement with earlier results24, we have not found any
obvious behavioural alterations, weight loss or sign of illness in mice fed a PLX3397
diet for 3 weeks or longer. Individual mice were observed for a 5-min period once
daily for any changes in activity, exploratory behaviour and social interaction.
Baseline temperature was recorded for every mouse before surgery or imaging.
No mice were excluded from these studies due to fever, weight loss, infection or
behavioural alterations as a result of PLX3397 diet.
AAV vector injection. The injection procedure was performed as described
previously54, with some modiﬁcations. A 0.5-mm hole was opened in the skull with
the tip of a dental drill over the S1 cortical region (centred 1.5mm lateral and
1.5mm posterior to the bregma). A glass micropipette was lowered 300 mm under
the pia, at a 60 angle towards the imaging area to minimize tissue disturbance
at the imaging site, followed by slow injection (300 nl over 5min) of either
AAV1.Syn.GCaMP6s.WPRE.SV40 or AAV1.Syn.RCaMP1h.WPRE.SV40 viral
vectors (Penn Vectore Core, Philadelphia, PA; titre 6.32 1011 IUml 1).
Cranial window surgery. Two weeks after injection mice were anaesthetized using
isoﬂurane (3% for induction, 1.5–2% during surgery). First, a custom-made
aluminium head plate was ﬁxed to the skull using cyanoarcylate glue and dental
cement. Then, the skull was either thinned to 20 mm over the imaging site or a
circular craniotomy (3mm diameter) was made above the S1 cortex (centred
2.7mm lateral and 1mm posterior to the bregma) without touching the dura
mater. During drilling, the place of craniotomy was rinsed continuously with cold
Ringer solution. The location of the imaging window was deﬁned in a separate set
of experiments by series of CBF measurements using laser Doppler ﬂowmetry
(30 measurements performed at 6 different sites, in n¼ 5 mice). This was done by
recording baseline blood ﬂow followed by the occlusion of the MCA with an
intraluminal ﬁlament for B15 s after which reperfusion was induced and the
Doppler probe repositioned repeating this procedure several times between the
MCA and the midline in the same mouse. The area of the craniotomy was covered
with a 3-mm cover glass and ﬁxed with dental cement. In preliminary experiments,
microglial activation and neuronal calcium responses were assessed in the case
of thinned skull preparations and after craniotomy without dura mater injury.
No changes in neuronal calcium signals, microglial CD45, Iba1 or Cx3Cr1
expression were found in either case as opposed to craniotomy with durectomy
(Supplementary Fig. 1, and not shown).
Imaging fast calcium responses and BBB injury. All experiments were
performed on a Femto2D-DualScanhead microscope (Femtonics Ltd., Budapest,
Hungary). Laser pulses were generated by a Mai Tai HP laser (SpectraPhysics,
Santa Clara, CA) or by a Chameleon Ultra II laser (Coherent, Inc., Santa Clara,
CA). The wavelength was set to 910 nm for GCaMP6s and to 980 nm when
RCaMP1 and microglia in Cx3Cr1GFP/þmice were measured simultaneously. For
excitation and signal collection, a CFI75 LWD 16XW/0.8 lens (Nikon, 16 , NA
0.8) was used, separated using a dichroic mirror (700dcxru, Chroma Technology)
before the two channel detector unit, which was sitting on the objective arm
(travelling detector system) as described in detail elsewhere55,56. The DualScanhead
microscope (Femtonics Ltd., Budapest, Hungary) is coupled with two parallel light
paths, which allows imaging at the same imaging site either with a galvanic mirror
or with resonant scanner without moving or changing the sample. First, the
galvo-scanning light path was used to acquire Z-stacks from 200 to 80 mm under
the dura mater, with 12 images per stack at 800 800 pixel resolution (0.75mm per
pixel). Then, the light path was changed to the resonant scanning mode and
two-photon imaging at video rate (31.25 frames per second) was performed at
512 512 pixel resolution (1 mm per pixel) for 60–120 s. This protocol was
repeated every 5min over the whole (5.5–6 h) imaging period for cerebral
ischaemia studies. Data acquisition was performed by MesC softver (Femtonics
Ltd.). To image microglia in Cx3Cr1GFP/þ mice simultaneously with the
assessment of BBB injury the galvo-scanning light path was used. Z-stacks
were recorded in the cerebral cortex (same area as used for neuronal calcium
measurements) continuously from 200 mm to 110 mm under the dura mater every
3min for a 5–6 h period before, and after the onset of ischaemia. Integrated density
(area of the ROI the mean of the ROI) was assessed at 6–6 randomly selected
areas over the brain parenchyma and the glia limitans in every stack, using ImageJ.
Integrated density values were expressed as a percentage of baseline (IntDen%).
The occlusion of the MCA during in vivo two-photon imaging was veriﬁed
by blood ﬂow velocity changes measured using the line-scan mode of the
galvo-scanning light path. Dextran rhodamine signal was recorded along a linear
scanning trajectory perpendicular to the blood vessels’ wall (measuring a single,
1.5 mm linear line with 3–5 kHz temporal resolution) on the red channel. Blood
ﬂow velocity was calculated as earlier57. Three mice in total were excluded from the
imaging studies pre hoc, one control mouse after cerebral ischaemia due to
improper laser intensity during imaging and two (one control and one microglia
depleted) mice from KCl studies due to inappropriate anaesthesia.
SD induction with KCl solution. In one group of mice, a small area of the cranial
window was left uncovered laterally to the cover glass (where the dura mater was
not injured). The dura mater was focally opened using a syringe needle and SD was
induced by applying 100mM KCl solution to the surface of the brain for 25min.
Three repeated SD induction periods were recorded. During SD induction, animals
were continuously imaged with resonant scanning for repeated 2min periods.
Then, a 15-min resting period was put in the protocol when the KCl solution was
replaced with Ringer solution until the beginning of the next SD induction. In a set
of studies, local ﬁeld potential was measured simultaneously with GCaMP6s signal
changes before and after KCl application, using a borosilicate glass electrode
(B0.1MO) ﬁlled with ACSF. Recordings were made in IC mode at 0mV holding
potential.
Remote ﬁlament model of MCAo. Cranial window preparation was followed by
remote ﬁlament implantation under isoﬂurane anaesthesia. The common carotid,
the external carotid and the internal carotid arteries were exposed and the common
carotid artery temporarily clipped. A 5 cm long, 5.0 monoﬁlament with silicon
rubber coating (210 mm tip diameter), residing in a silicone guiding tube was
introduced into the left external carotid artery and advanced along the internal
carotid artery up to 8mm, without occluding the MCA. Blood ﬂow was restored in
the common carotid artery and the silicone guiding tube was secured, followed by
closure of the wound at the site of surgery, to allow free manipulation of the
monoﬁlament during in vivo two-photon imaging. Mice were positioned into the
two-photon microscope, after which 15–30min baseline imaging was performed
followed by the induction of 60min of MCA occlusion and 4–5 h reperfusion.
Middle cerebral artery occlusion. MCAo was performed using the intraluminal
ﬁlament technique as described earlier58. In brief, animals were anaesthetized with
isoﬂurane and a silicone-coated monoﬁlament (210 mm tip diameter, Doccol, US)
was introduced into the left external carotid artery and advanced along the internal
carotid artery to occlude the MCA for 45min. Occlusion was conﬁrmed by
a laser Doppler (Moor Instruments, UK). During surgery, core temperature was
maintained at 37±0.5 C. After experimental stroke, four mice were excluded
pre hoc due to incomplete occlusion of the MCA or surgical artifacts.
Tissue processing and immunostaining. After terminal anaesthesia, mice were
perfused transcardially with saline followed by ice-cold 4% paraformaldehyde.
Brains and spleens were post-ﬁxed for 24 h, cryoprotected in 10% sucrose/PBS and
sectioned (25mm diameter) on a sledge microtome. Detection of IgG leakage to the
brain parenchyma by immunostaining (Vector, NBA-2000, horse anti-mouse
biotynilated IgG 1:500) was used to assess BBB permeability on brain sections
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as described earlier58. Immunoﬂuorescence was performed on free-ﬂoating brain
sections using combinations of rabbit anti-Iba1 (WAKO, 019-19741, 1:500),
rat anti-CD45 (AbDSerotec, MCA1388, 1:250), mouse anti-GFAP (Sigma, G3893,
1:500), rabbit anti-Claudin-5 (Invitrogen, 34-1600, 1:500) and goat anti-PDGFRb
(R&D Systems, AF1042, 1:500) antibodies. Sections were incubated in a primary
antibody cocktail overnight followed by adequate ﬂuorochrome (Invitrogen,
A21206, donkey anti-rabbit Alexa 488 1:500; Invitrogen, A21203, donkey-anti-
mouse Alexa 594 1:500)-conjugated antibodies. Biotinylated tomato lectin
(Sigma-Aldrich, L0651-1mg, 1:100) was used to visualize blood vessels, followed by
streptavidin Alexa 350 conjugate (Invitrogen, S11249, 1:200). Images were captured
using a Zeiss Axiovert 200M microscope with Axiovision 4.8 software.
Super-resolution microscopy. Free-ﬂoating brain sections were blocked with
2% normal donkey serum followed by immunostaining with rabbit anti-P2Y12
(Anaspec, AS-55043A, 1:500) antibody and anti-rabbit Alexa 647 secondary
antibody (Jackson ImmunoResearch, 711-605-152, 1:400). Neurons were visualized
by GCaMP6s signal and astrocytes detected using a mouse anti-GFAP antibody
(Sigma, G3893, 1:500) developed by anti-mouse DyLight 405-Streptavidin
secondary antibody (Jackson ImmunoResearch, 016-470-084, 1:400). Sections were
mounted onto #1.5 borosilicate coverslips and covered with imaging medium
containing 5% glucose, 0.1M mercaptoethylamine, 1mgml 1 glucose oxidase,
and catalase (Sigma, 1500Uml 1) in Dulbecco’s PBS (Sigma), immediately before
imaging59. STORM imaging was performed for P2Y12 (stimulated by a 647 nm
laser) by using a Nikon N-STORM C2þ super-resolution system that combines
‘Stochastic Optical Reconstruction Microscopy’ technology and Nikon’s Eclipse
Ti research inverted microscope to reach a lateral resolution of 20 nm and axial
resolution of 50 nm (refs 60,61).
Cytokine measurement. IL-6 was measured in cerebrospinal ﬂuid samples and
IL-1a, IL-1b, TNFa, IFNg, IL-6, MCP-1, RANTES (CCL5), G-CSF, KC (CXCL1),
IL-10 and IL-4 were measured in homogenates of saline perfused ipsilateral and
contralateral brain hemispheres62 by cytometric bead array using CBA Flex Sets
(all from BD Biosciences, 560157, 560232, 558299, 558296, 558301, 558342,
558345, 560152, 558340, 558300, 558294, respectively). Measurements were
performed on a BD FACSVerse machine and data analysed using FCAP Array
software (BD Biosciences). Brain tissue cytokine levels were corrected for the
total protein content of the samples as measured by BCA assay (Pierce).
Flow cytometry. Following Fc receptor blockade (eBioscience, 16-0161-85
anti-mouse CD16/CD32, 1:100), blood cells and splenic leukocytes cells were
stained with cocktails of selected antibodies: T cells (all from eBioscience,
11-0043-82 anti-mouse CD4-FITC, 1:100; 12-0081-82 anti-mouse CD8a-PE,
1:400; 17-0031-80 anti-mouse CD3e-APC, 1:200), B cells (all from eBioscience,
11-0193-81 anti-mouse CD19-FITC, 1:100; 17-5321-81 anti-mouse MHCII
(I-A/I-E)-APC, 1:400); granulocytes/monocytes (all from eBioscience, 11-0112-81
anti-mouse CD11b-FITC, 1:100; 25-5932-80 anti-mouse Ly-6C-PE-Cy7, 1:400)
and macrophages (BD Biosciences, 563900 rat anti-mouse F4/80-like receptor-
Violet, 1:200). Antibodies were purchased from eBioscience. Cells were acquired on
a BD FACSVerse ﬂow cytometer (BD Biosciences, US) and data were analysed
using FACSuite software (BD Biosciences). Total blood cell counts were calculated
by using 15 mm polystyrene microbeads (Polysciences, 18328-5).
Quantitative analysis. Animals were randomized for MCAo experiments using
GraphPad Random Number Generator. All quantitative analysis was performed
under blinded conditions. The volume of ischaemic brain damage was measured
on cresyl violet-stained brain sections. Infarct size and BBB injury at 24 h
reperfusion were calculated by integration of areas of damage measured at eight
neuroanatomically deﬁned coronal levels (between 2.9mm rostral and  4.9mm
caudal to bregma) with the distance between coronal levels followed by correction
for oedema, as described previously58. Quantitative analysis of immunostaining
was performed on at least three, randomly selected ﬁelds within the region of
interest for each brain section, on 4-4 serial coronal sections separated by 400 mm
for the striatum and 800 mm for the cerebral cortex (between 0.8 posterior and 0.8
anterior and between 2.4 posterior and 0.8 anterior to the bregma, respectively).
The border of infarct was deﬁned on cresyl violet-stained brain sections and
microglial activation was also visualized on adjacent sections based on Iba1
immunoﬂuorescence. Two-photon image sequences were analysed using ImageJ.
Measurement units were collected from MesC ﬁles with HDF5 importer plugin.
Background intensity was measured in a dark region of the ﬁeld of view and was
subtracted from each image sequence. The GCaMP6s signal of individual neurons
was collected with ImageJ Plot-axis Z proﬁle into the MES (Femtonics Ltd.) curve
analysis modul. The trace of the individual cells was normalized to the baseline
level of signal (a time interval without calcium activity, typically the begining of the
imagig sequence). Then, the area under the curve was calculated for calcium curves
after cerebral ischaemia or SD induction with KCl. Microglia-neuron interactions
were assessed on Z-stacks recorded every 3min between 200 and 11 mm under the
dura mater. Microglia contacting neurons were randomly selected and neurons
showing at least 1.5-foldchange in RCaMP1 signal were used to study microglial
process recruitment over a 150min period after the onset of ischaemia. The net
extension/withdrawal of microglial processes to individual neurons was plotted
against relative RCaMP1 signal intensity changes measured during the same
period. Changes in microglial ramiﬁcation were investigated with Sholl analysis as
described earlier33. Two-photon images of individual microglial cells were
converted into a minimum intensity projection image using the concentric circles
plugin of the ImageJ with a 2 mm step size. The intercesctions between the circles
and the cell processes were calculated manually for each cell. To evaluate microglia
process recruitment to neuronal soma, a concentric circle macro (modiﬁcation of a
Sholl analysis) was written for Fiji. Microglia process coverage around neurons was
assessed in 30 circles (0.5 mm step size) with an r step of 4. For three-dimensional
reconstruction of in vivo two-photon images at different Z-planes to visualize
the relationship between neuronal RCaMP1 and microglial processes in
Cx3Cr1GFP/þmice, the Simple Neurite Tracer plugin (Fiji) was used.
Statistics. Group sizes for MCAo studies with infarct size assessment were
determined by power calculation (GPower 3.1) based on results from our
representative previous studies (a error probability: 0.05, power: 0.8 and an
estimated 20% s.d.). This resulted in n¼ 7 for two experimental groups (Cohen’s
d effect size: 1.66) and n¼ 9 for four experimental groups (effect size f: 0.6). No
formal power calculation was performed for imaging studies. Data were analysed
using Student’s t-test or Mann–Whitney test (comparing two experimental
groups), one-way or two-way analysis of variance followed by Tukey’s and Sidak’s
post hoc comparison, respectively (comparing three or more groups) and linear
regression was used for correlation analysis (GraphPad Prism 6.0). Po0.05 was
considered statistically signiﬁcant.
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